Trends in outpatient emergency department visits during the COVID-19 pandemic at a large, urban, academic hospital system.


Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 21 10 2020
revised: 01 12 2020
accepted: 04 12 2020
pubmed: 19 12 2020
medline: 26 2 2021
entrez: 18 12 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic has critically affected healthcare delivery in the United States. Little is known on its impact on the utilization of emergency department (ED) services, particularly for conditions that might be medically urgent. The objective of this study was to explore trends in the number of outpatient (treat and release) ED visits during the COVID-19 pandemic. We conducted a cross-sectional, retrospective study of outpatient emergency department visits from January 1, 2019 to August 31, 2020 using data from a large, urban, academic hospital system in Utah. Using weekly counts and trend analyses, we explored changes in overall ED visits, by patients' area of residence, by medical urgency, and by specific medical conditions. While outpatient ED visits were higher (+6.0%) in the first trimester of 2020 relative to the same period in 2019, the overall volume between January and August of 2020 was lower (-8.1%) than in 2019. The largest decrease occurred in April 2020 (-30.4%), followed by the May to August period (-12.8%). The largest declines were observed for visits by out-of-state residents, visits classified as non-emergent, primary care treatable or preventable, and for patients diagnosed with hypertension, diabetes, headaches and migraines, mood and personality disorders, fluid and electrolyte disorders, and abdominal pain. Outpatient ED visits for emergent conditions, such as palpitations and tachycardia, open wounds, syncope and collapse remained relatively unchanged, while lower respiratory disease-related visits were 67.5% higher in 2020 relative to 2019, particularly from March to April 2020. However, almost all types of outpatient ED visits bounced back after May 2020. Overall outpatient ED visits declined from mid-March to August 2020, particularly for non-medically urgent conditions which can be treated in other more appropriate care settings. Our findings also have implications for insurers, policymakers, and other stakeholders seeking to assist patients in choosing more appropriate setting for their care during and after the pandemic.

Sections du résumé

BACKGROUND BACKGROUND
The coronavirus disease 2019 (COVID-19) pandemic has critically affected healthcare delivery in the United States. Little is known on its impact on the utilization of emergency department (ED) services, particularly for conditions that might be medically urgent. The objective of this study was to explore trends in the number of outpatient (treat and release) ED visits during the COVID-19 pandemic.
METHODS METHODS
We conducted a cross-sectional, retrospective study of outpatient emergency department visits from January 1, 2019 to August 31, 2020 using data from a large, urban, academic hospital system in Utah. Using weekly counts and trend analyses, we explored changes in overall ED visits, by patients' area of residence, by medical urgency, and by specific medical conditions.
RESULTS RESULTS
While outpatient ED visits were higher (+6.0%) in the first trimester of 2020 relative to the same period in 2019, the overall volume between January and August of 2020 was lower (-8.1%) than in 2019. The largest decrease occurred in April 2020 (-30.4%), followed by the May to August period (-12.8%). The largest declines were observed for visits by out-of-state residents, visits classified as non-emergent, primary care treatable or preventable, and for patients diagnosed with hypertension, diabetes, headaches and migraines, mood and personality disorders, fluid and electrolyte disorders, and abdominal pain. Outpatient ED visits for emergent conditions, such as palpitations and tachycardia, open wounds, syncope and collapse remained relatively unchanged, while lower respiratory disease-related visits were 67.5% higher in 2020 relative to 2019, particularly from March to April 2020. However, almost all types of outpatient ED visits bounced back after May 2020.
CONCLUSIONS CONCLUSIONS
Overall outpatient ED visits declined from mid-March to August 2020, particularly for non-medically urgent conditions which can be treated in other more appropriate care settings. Our findings also have implications for insurers, policymakers, and other stakeholders seeking to assist patients in choosing more appropriate setting for their care during and after the pandemic.

Identifiants

pubmed: 33338676
pii: S0735-6757(20)31126-8
doi: 10.1016/j.ajem.2020.12.009
pmc: PMC7725055
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-26

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest All authors report not conflict of interest.

Références

Intern Med J. 2013 Jan;43(1):59-65
pubmed: 22646852
Med Care. 2020 Feb;58(2):137-145
pubmed: 31651740
Med Care. 2010 Jan;48(1):58-63
pubmed: 19952803
JAMA. 2020 Jul 21;324(3):231-232
pubmed: 32496531
Am J Emerg Med. 2005 Mar;23(2):131-7
pubmed: 15765330
N Engl J Med. 2020 Apr 30;382(18):1679-1681
pubmed: 32160451
JAMA. 2020 Jul 7;324(1):96-99
pubmed: 32501493
JAMA. 2020 Jun 16;323(23):2375-2376
pubmed: 32421170
Pediatrics. 2011 Feb;127(2):e375-81
pubmed: 21242226
JAMA Intern Med. 2020 Oct 1;180(10):1328-1333
pubmed: 32744612
Am Surg. 2020 Aug;86(8):901-903
pubmed: 32909462
Am J Emerg Med. 2020 Sep;38(9):1732-1736
pubmed: 32738468
Health Serv Res. 2017 Aug;52(4):1264-1276
pubmed: 28726238
JAMA. 2018 Nov 27;320(20):2147-2149
pubmed: 30480716
Issue Brief (Commonw Fund). 2000 Nov;(433):1-5
pubmed: 11665698
JAMA. 2020 Jul 21;324(3):233-234
pubmed: 32530458
N Engl J Med. 2020 Aug 13;383(7):691-693
pubmed: 32427432
Am J Emerg Med. 2011 Mar;29(3):333-45
pubmed: 20825838
Am J Manag Care. 2013 Jan;19(1):47-59
pubmed: 23379744
Health Aff (Millwood). 2020 Nov;39(11):2010-2017
pubmed: 32970495
MMWR Morb Mortal Wkly Rep. 2020 Jun 12;69(23):699-704
pubmed: 32525856

Auteurs

Theodoros V Giannouchos (TV)

Pharmacotherapy Outcomes Research Center, College of Pharmacy, University of Utah, Salt Lake City, UT, United States of America. Electronic address: theo.giannouchos@utah.edu.

Joseph Biskupiak (J)

Pharmacotherapy Outcomes Research Center, College of Pharmacy, University of Utah, Salt Lake City, UT, United States of America.

Michael J Moss (MJ)

Division of Emergency Medicine, Department of Surgery, University of Utah, Salt Lake City, UT, United States of America; Utah Poison Control Center, College of Pharmacy, University of Utah, Salt Lake City, UT, United States of America.

Diana Brixner (D)

Pharmacotherapy Outcomes Research Center, College of Pharmacy, University of Utah, Salt Lake City, UT, United States of America.

Elena Andreyeva (E)

Department of Health Policy & Management, School of Public Health, Texas A&M University, College Station, TX, United States of America.

Benjamin Ukert (B)

Department of Health Policy & Management, School of Public Health, Texas A&M University, College Station, TX, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH